retatrutide phase 3 trial results for have been released, and the data are generating a lot of discussion in obesity medicine. TRIUMPH-1 enrolled 2,339 adults with obesity or overweight and followed participants for Retatrutide just delivered the first
Description
GLP-1 and AMPK pathway The AMPK controls cellular energy balance
Obesity and lipoprotein cholesterol in the Framingham offspring study
The pitch goes something like hormones plus a fat-loss peptide better results than Mounjaro for less money. We see patients arrive with questions about this every week
A July 2025 study published in Nutrients (PubMed: 40806100) found that Akkermansia extracts induced a robust, dose-dependent rise in GLP-1 secretion from human L-cells in vitro
Heesakker, G
